Exin Therapeutics, Inc. funding
Exin Therapeutics, Inc., a biotechnology company based in San Francisco, CA (founded 2024), filed a Form D with the SEC on February 10, 2026 and reported $2.2M raised.
Amount raised$2.2M
Offering size$2.2M
Filed with the SECFebruary 10, 2026
First saleNovember 18, 2024
IndustryBiotechnology
SecuritiesOptions or warrants, Security to be acquired on exercise
LocationSan Francisco, CA
Founded2024
Entity typeCorporation
Investors so far28
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Feb 10
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology